PL1905444T3 - Sposób wytwarzania kompozycji leczniczej zawierającej drugorzędowe glikozydy żeń-szenia - Google Patents

Sposób wytwarzania kompozycji leczniczej zawierającej drugorzędowe glikozydy żeń-szenia

Info

Publication number
PL1905444T3
PL1905444T3 PL06761360T PL06761360T PL1905444T3 PL 1905444 T3 PL1905444 T3 PL 1905444T3 PL 06761360 T PL06761360 T PL 06761360T PL 06761360 T PL06761360 T PL 06761360T PL 1905444 T3 PL1905444 T3 PL 1905444T3
Authority
PL
Poland
Prior art keywords
preparation
composition containing
medicinal composition
containing ginseng
ginseng secondary
Prior art date
Application number
PL06761360T
Other languages
English (en)
Inventor
Congxin Sun
Hesheng Luo
Yongli Zhao
Original Assignee
Shanghai Hongyitang Biopharmaceutical Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 200510083852 external-priority patent/CN1718191A/zh
Priority claimed from CNB2005100838556A external-priority patent/CN100337636C/zh
Priority claimed from CN 200510083854 external-priority patent/CN1718193A/zh
Application filed by Shanghai Hongyitang Biopharmaceutical Tech Co Ltd filed Critical Shanghai Hongyitang Biopharmaceutical Tech Co Ltd
Publication of PL1905444T3 publication Critical patent/PL1905444T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
PL06761360T 2005-07-14 2006-07-05 Sposób wytwarzania kompozycji leczniczej zawierającej drugorzędowe glikozydy żeń-szenia PL1905444T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN 200510083852 CN1718191A (zh) 2005-07-14 2005-07-14 人参总次苷口腔崩解片及其制备方法和应用
CNB2005100838556A CN100337636C (zh) 2005-07-14 2005-07-14 一种人参总次苷药物组合物及其制备方法和应用
CN 200510083854 CN1718193A (zh) 2005-07-14 2005-07-14 一种人参总次苷药物组合物及其制法和在制备治疗心肌缺血及失血性休克药物中的应用
PCT/CN2006/001574 WO2007006208A1 (en) 2005-07-14 2006-07-05 Medicinal composition containing ginseng secondary glycosides, its preparation method and application
EP06761360.4A EP1905444B1 (en) 2005-07-14 2006-07-05 Preparation method of a medicinal composition containing ginseng secondary glycosides

Publications (1)

Publication Number Publication Date
PL1905444T3 true PL1905444T3 (pl) 2015-03-31

Family

ID=37636737

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06761360T PL1905444T3 (pl) 2005-07-14 2006-07-05 Sposób wytwarzania kompozycji leczniczej zawierającej drugorzędowe glikozydy żeń-szenia

Country Status (8)

Country Link
US (1) US7973014B2 (pl)
EP (1) EP1905444B1 (pl)
JP (1) JP2009500432A (pl)
KR (1) KR101182917B1 (pl)
CA (1) CA2614700C (pl)
ES (1) ES2515891T3 (pl)
PL (1) PL1905444T3 (pl)
WO (1) WO2007006208A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100856083B1 (ko) * 2007-03-15 2008-09-03 (주)뉴트리 홍삼 특이 사포닌 고함유 인삼엑기스의 효율적인 제조방법
RU2463070C1 (ru) * 2008-07-23 2012-10-10 Хэбэй Илин Медицин Рисёч Инститьют Ко., Лтд. Фармацевтическая композиция для регуляции калиевых каналов в клетке сердечной мышцы, способ ее получения и ее применения
KR100919134B1 (ko) * 2008-10-22 2009-09-25 (주)해나천연물연구소 항비만 효능을 나타내는 저극성 진세노사이드를 고농도로 함유하는 인삼 추출물 및 이의 제조방법
KR101011254B1 (ko) * 2008-12-10 2011-01-27 건국대학교 산학협력단 과염소산의 산 가수분해를 이용한 진세노사이드 아글리콘 프로토파낙사디올 제조방법
JP5550995B2 (ja) * 2009-06-12 2014-07-16 ライオン株式会社 尿酸値低下組成物
JP5546851B2 (ja) * 2009-12-21 2014-07-09 ライオン株式会社 貧血改善剤及び貧血改善用組成物
CN102600214B (zh) * 2011-01-24 2014-10-08 北京大学 苦丁茶冬青叶的提取方法、总皂苷及其用途
CN102731603A (zh) * 2011-03-31 2012-10-17 上海兰蒂斯生物医药科技有限公司 人参二醇及20(r)-原人参二醇的制备方法
CN103857690B (zh) 2011-08-19 2017-04-05 艾昆西恩斯公司 蛋白质检测
CN103372138B (zh) * 2012-04-25 2017-07-28 天士力制药集团股份有限公司 一种含有生脉饮有效成分的药物组合物及其制备方法
JP6163359B2 (ja) * 2012-06-19 2017-07-12 花王株式会社 Ｃｇｒｐ応答性促進剤
JP6076719B2 (ja) * 2012-12-06 2017-02-08 花王株式会社 Ｃｇｒｐ応答性促進剤
CN103271891B (zh) * 2013-04-28 2016-01-06 福建南方制药股份有限公司 人参皂苷纳米胶束及其制备方法、应用和药物组合物
CN103242408B (zh) * 2013-05-08 2016-01-13 天津大学 微波辅助技术提取人参皂苷单体Rg3和Rh2的方法
CN107073023B (zh) * 2015-07-16 2020-03-17 智能合成生物中心 血管渗漏综合症的预防或治疗组合物
CN105055801A (zh) * 2015-08-28 2015-11-18 霍同颜 一种医治心律失常的组合物及制法
CN108339000B (zh) * 2017-01-22 2021-08-03 上海弘医堂生物医药科技有限公司 一种人参属植物提取物及其药物组合物和应用
KR102095536B1 (ko) 2019-06-04 2020-03-31 (주)녹십자웰빙 천연물 추출물의 용출률 및 붕해성이 개선된 경구용 제제
CN111228277B (zh) * 2020-03-11 2023-07-07 大连大学 20(R)-25-羟基-达玛烷型-3β,12β,20-三醇的药物用途
CN111802613B (zh) * 2020-07-14 2022-10-11 广东老中医保健食品有限公司 人参皂苷掩味剂、含人参皂苷的具留长麦香风味组合物、口含片及其制作方法
CN112646081A (zh) * 2020-12-07 2021-04-13 石河子大学 新型硼酸功能化大孔树脂的制备以及在甜菊糖苷选择吸附中的应用
CN114910573A (zh) * 2021-02-10 2022-08-16 陕西中医药大学附属医院 一种用于体外细胞培养的中药含药血清制备及鉴定方法
CN113331421A (zh) * 2021-06-22 2021-09-03 北京澳特舒尔保健品开发有限公司 总皂苷的制备方法及其在改善睡眠、祛斑产品中的应用
CN116120389B (zh) * 2023-03-29 2023-07-18 中国农业科学院特产研究所 人参皂苷Rg5及制备和在制备过敏性鼻炎药物中的应用
CN116999449B (zh) * 2023-08-17 2024-05-03 吉林农业大学 一种人参皂苷组合物及其在制备多靶点脂肪细胞发育分化和代谢调节剂中的应用
CN117323270B (zh) * 2023-11-29 2024-03-19 江西康一参生物科技有限公司 一种抗炎症多功效的人参组合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533456A (en) * 1978-08-31 1980-03-08 Koshiro Chiyuuji Shoten:Kk Separation of ginseng saponin
CN1049296C (zh) 1994-01-06 2000-02-09 东南大学 多工位半自动灯管对接机
JP3087638B2 (ja) 1995-11-30 2000-09-11 ヤマハ株式会社 音楽情報処理システム
CN1193038A (zh) 1997-03-06 1998-09-16 宋建民 加重防污染剂
CN1092204C (zh) * 1998-07-28 2002-10-09 吉林大学基础医学院科技开发中心 20(S)－人参皂甙Rg3的半合成方法及其药物用途
CN1156281C (zh) * 2000-01-31 2004-07-07 吉林省中医中药研究院 人参皂甙Rg2在制备治疗心、脑血管疾病药物中的应用
US8486464B2 (en) 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US6888014B2 (en) 2001-07-24 2005-05-03 Panagin Pharmaceuticals Inc. Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
CN1193038C (zh) * 2001-11-06 2005-03-16 中国科学院大连化学物理研究所 一种人参皂甙酸水解制备人参皂甙Rg#－[3]的方法
KR20040036451A (ko) 2002-10-26 2004-04-30 한국과학기술연구원 진세노사이드 Ｒｇ３ 또는 진세노사이드 Ｒｈ２를포함하는 글루타메이트 매개 신경독성 억제 조성물
CN1331473C (zh) 2003-07-23 2007-08-15 山东绿叶天然药物研究开发有限公司 20（S）—人参皂苷—Rg3在制备治疗或预防心脑血管疾病的药物中的应用
CN1569011A (zh) 2003-07-24 2005-01-26 山东绿叶天然药物研究开发有限公司 20（R）－人参皂苷－Rg3在制备治疗或预防心脑血管疾病的药物中的应用
EP1660107A4 (en) * 2003-08-18 2008-06-04 Yuyu Inc GINSENG PREPARATION USING VINEGAR AND MANUFACTURING METHOD THEREFOR
CN100339085C (zh) * 2003-09-23 2007-09-26 天津天士力制药股份有限公司 治疗心脑血管疾病的中药组合物
CN1283267C (zh) 2004-07-19 2006-11-08 北京科信必成医药科技发展有限公司 人参茎叶总皂苷口腔崩解片制剂及其制备方法
US7371131B2 (en) 2005-04-04 2008-05-13 Fci Americas Technology, Inc. Connector having retentive rib
US8018761B2 (en) 2006-12-28 2011-09-13 Panasonic Corporation Resistance variable element, resistance variable memory apparatus, and resistance variable apparatus
CN101586589A (zh) 2008-05-21 2009-11-25 煤炭科学研究总院上海分院 电液运动一体化模块装置

Also Published As

Publication number Publication date
US20080234208A1 (en) 2008-09-25
KR20080034154A (ko) 2008-04-18
JP2009500432A (ja) 2009-01-08
EP1905444A1 (en) 2008-04-02
CA2614700C (en) 2011-07-19
US7973014B2 (en) 2011-07-05
EP1905444B1 (en) 2014-09-24
CA2614700A1 (en) 2007-01-18
KR101182917B1 (ko) 2012-09-13
WO2007006208A1 (en) 2007-01-18
HK1110520A1 (en) 2008-07-18
EP1905444A4 (en) 2011-11-30
ES2515891T3 (es) 2014-10-30

Similar Documents

Publication Publication Date Title
PL1905444T3 (pl) Sposób wytwarzania kompozycji leczniczej zawierającej drugorzędowe glikozydy żeń-szenia
IL189589A0 (en) Method for preparation of pharmaceutical composition having improved disintegratability
SG131857A1 (en) δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ZA200900347B (en) Preparation of pharmaceutical compositions
IL178775A0 (en) Pharmaceutical compositions for acute glucocorticoid therapy
IL187330A0 (en) A method of marking composition for oral administration
ZA200808631B (en) Solid oral form of a medicinal preparation and a method for the production thereof
GB0521708D0 (en) Method of preparing a pharmaceutical composition and pharmaceutical compositions obtainable thereby
ZA200606455B (en) Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
IL184895A0 (en) Pharmaceutical compositions containing glucuronidated nebivolol metabolites
IL177173A0 (en) New crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it
SG151172A1 (en) 1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
AP2009004773A0 (en) Process for preparing a composition comprising steroidal glycosides
ZA200606454B (en) Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
EP1806148A4 (en) THERAPEUTIC PREPARATION FOR INHALATION
AP1930A (en) Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it
EP2111285B8 (en) A method for the preparation of a reducing agent composition
ZA200602631B (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
EP1811967A4 (en) METHOD AND FORMULATIONS FOR PREPARING PHARMACEUTICAL COMPOSITIONS WITH BUPROPION
EP1872784A4 (en) MEDICAL PREPARATION FOR PERCUTANEOUS ABSORPTION
ZA200603810B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200904979B (en) Herbal composition and process for its preparation
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide
ZA200603809B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them